SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe